Post-earnings recap
Reported
Fri, May 13, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Catalyst Pharmaceuticals reported a loss of $0.08 per share, with no revenue figures available. The stock reacted negatively, declining by 1.71%. The lack of guidance and details from the earnings call may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.08 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.